Baidu
map

Radiology:非强化电影MR图像在亚急性和慢性心肌梗死瘢痕纹理分析准确性的价值。

2017-08-30 shaosai MedSci原创

心肌梗死又叫心肌梗塞,心肌梗塞(myocardialinfarction, MI)是冠状动脉闭塞,血流中断,使部分心肌因严重的持久性缺血而发生局部坏死。临床上有剧烈而较持久的胸骨后疼痛,发热、白细胞增多、红细胞沉降率加快,血清心肌酶活力增高及进行性心电图变化,可发生心律失常、休克或心力衰竭。本研究旨在测试利用非强化电影心脏磁共振(MR)纹理分析(TA)诊断亚急性和慢性心肌梗死的价值,并将结果发表在

心肌梗死又叫心肌梗塞,心肌梗塞(myocardialinfarction, MI)是冠状动脉闭塞,血流中断,使部分心肌因严重的持久性缺血而发生局部坏死。临床上有剧烈而较持久的胸骨后疼痛,发热、白细胞增多、红细胞沉降率加快,血清心肌酶活力增高及进行性心电图变化,可发生心律失常、休克或心力衰竭。本研究旨在测试利用非强化电影心脏磁共振(MR)纹理分析(TA)诊断亚急性和慢性心肌梗死的价值,并将结果发表在Radiology上。

本研究回顾性分析了120例行心脏MR检查的患者,包括亚急性和慢性大面积透壁性梗死(延迟期(LGE)图像上强化体积比例>20%, n = 72)和小灶性透壁性梗死(强化体积比例≤20%, n = 48);并有6例正常心脏MR图像作为对照组。利用免费软件,在收缩末期的电影图像上由两名观察者独立采用盲法对左心室感兴趣区进行TA。以LGE成像作为参考标准,利用基于可重复性的逐步降维法和纹理特征选择、机器学习和相关性分析来选择特征,在非强化电影MR图像上诊断MI。

结果为,在各亚组(Teta1,Perc.01,Variance,WavEnHH.s-3和S(5,5)SumEntrp(在大面积MI:所有P< .001;在小面积MI:Teta1 和Perc.01, P < .001; Variance, P = .026; WavEnHH.s-3, P = .007; S[5,5]SumEntrp, P = .045)),共有5种独立纹理特征能够在电影MR图像上鉴别缺血性心肌和正常心肌。多元Logistic回归模型表明结合特征Teta1和Perc.01在电影MR图像上诊断大面积MI和小面积MI具有最高的准确率,曲线下面积分别为0.93、0.92。

本概念研究研究表明,非强化电影MR图像的TA对诊断亚急性和慢性MI具有较高的准确率。

原始出处:

Baessler B, Mannil M, Oebel S, Fuentes DT, et al,Subacute and Chronic Left Ventricular Myocardial Scar: Accuracy of Texture Analysis on Nonenhanced Cine MR Images. Radiology. 2017.DOI: 10.1148/radiol.2017170213

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1905908, encodeId=925c190590858, content=<a href='/topic/show?id=34953120e52' target=_blank style='color:#2F92EE;'>#准确性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31207, encryptionId=34953120e52, topicName=准确性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Thu Aug 16 08:29:00 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642372, encodeId=add616423e2cc, content=<a href='/topic/show?id=ed51e75334a' target=_blank style='color:#2F92EE;'>#纹理分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77533, encryptionId=ed51e75334a, topicName=纹理分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=053b22916437, createdName=12498dd9m18暂无昵称, createdTime=Wed May 02 08:29:00 CST 2018, time=2018-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1336961, encodeId=baf7133696166, content=<a href='/topic/show?id=48f8e12220f' target=_blank style='color:#2F92EE;'>#瘢痕#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71222, encryptionId=48f8e12220f, topicName=瘢痕)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fa82500120, createdName=12498a1cm67暂无昵称, createdTime=Fri Sep 01 13:29:00 CST 2017, time=2017-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238811, encodeId=d68e23881120, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=08bb2061153, createdName=189****7206, createdTime=Thu Aug 31 00:00:58 CST 2017, time=2017-08-31, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1905908, encodeId=925c190590858, content=<a href='/topic/show?id=34953120e52' target=_blank style='color:#2F92EE;'>#准确性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31207, encryptionId=34953120e52, topicName=准确性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Thu Aug 16 08:29:00 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642372, encodeId=add616423e2cc, content=<a href='/topic/show?id=ed51e75334a' target=_blank style='color:#2F92EE;'>#纹理分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77533, encryptionId=ed51e75334a, topicName=纹理分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=053b22916437, createdName=12498dd9m18暂无昵称, createdTime=Wed May 02 08:29:00 CST 2018, time=2018-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1336961, encodeId=baf7133696166, content=<a href='/topic/show?id=48f8e12220f' target=_blank style='color:#2F92EE;'>#瘢痕#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71222, encryptionId=48f8e12220f, topicName=瘢痕)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fa82500120, createdName=12498a1cm67暂无昵称, createdTime=Fri Sep 01 13:29:00 CST 2017, time=2017-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238811, encodeId=d68e23881120, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=08bb2061153, createdName=189****7206, createdTime=Thu Aug 31 00:00:58 CST 2017, time=2017-08-31, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1905908, encodeId=925c190590858, content=<a href='/topic/show?id=34953120e52' target=_blank style='color:#2F92EE;'>#准确性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31207, encryptionId=34953120e52, topicName=准确性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Thu Aug 16 08:29:00 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642372, encodeId=add616423e2cc, content=<a href='/topic/show?id=ed51e75334a' target=_blank style='color:#2F92EE;'>#纹理分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77533, encryptionId=ed51e75334a, topicName=纹理分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=053b22916437, createdName=12498dd9m18暂无昵称, createdTime=Wed May 02 08:29:00 CST 2018, time=2018-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1336961, encodeId=baf7133696166, content=<a href='/topic/show?id=48f8e12220f' target=_blank style='color:#2F92EE;'>#瘢痕#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71222, encryptionId=48f8e12220f, topicName=瘢痕)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fa82500120, createdName=12498a1cm67暂无昵称, createdTime=Fri Sep 01 13:29:00 CST 2017, time=2017-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238811, encodeId=d68e23881120, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=08bb2061153, createdName=189****7206, createdTime=Thu Aug 31 00:00:58 CST 2017, time=2017-08-31, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1905908, encodeId=925c190590858, content=<a href='/topic/show?id=34953120e52' target=_blank style='color:#2F92EE;'>#准确性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31207, encryptionId=34953120e52, topicName=准确性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Thu Aug 16 08:29:00 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642372, encodeId=add616423e2cc, content=<a href='/topic/show?id=ed51e75334a' target=_blank style='color:#2F92EE;'>#纹理分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77533, encryptionId=ed51e75334a, topicName=纹理分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=053b22916437, createdName=12498dd9m18暂无昵称, createdTime=Wed May 02 08:29:00 CST 2018, time=2018-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1336961, encodeId=baf7133696166, content=<a href='/topic/show?id=48f8e12220f' target=_blank style='color:#2F92EE;'>#瘢痕#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71222, encryptionId=48f8e12220f, topicName=瘢痕)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fa82500120, createdName=12498a1cm67暂无昵称, createdTime=Fri Sep 01 13:29:00 CST 2017, time=2017-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238811, encodeId=d68e23881120, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=08bb2061153, createdName=189****7206, createdTime=Thu Aug 31 00:00:58 CST 2017, time=2017-08-31, status=1, ipAttribution=)]
    2017-08-31 189****7206

    学习了谢谢分享

    0

相关资讯

腹痛、血尿、干咳,捣乱的竟都是你……

主动脉夹层可谓灾难性疾病,一周内死亡率60% - 70%,3个月内死亡率可达90%,所以早期诊断及时治疗尤为重要。

Int J Nanomed:使用NPs负载利拉鲁肽或可有效治疗心肌梗死

局部心肌内注射蛋白质进入心肌梗死部位是心肌梗死后启动心肌再生的一个很好地治疗方法。已知利拉鲁肽是用于治疗2型糖尿病的药物,且是心肌再生的明星蛋白质之一。但是使用这种蛋白质治疗所面临的一个重大挑战是它在体内的半衰期很短。本实验旨在评估实验性心肌梗死中使用聚(乳酸-羟基乙酸)–聚(乙二醇)(PLGA–PEG)纳米粒(NP-利拉鲁肽)负载利拉鲁肽的治疗效果以及药物的长时间存留情况。结果显示,PLGA–P

JACC:低水平耳屏刺激治疗ST段抬高心梗的缺血-再灌注损伤

LL-TS降低STEMI患者的心肌缺血再灌注损伤。

咽喉痛小毛病?千万别被骗了!

我们都知道,典型的冠心病症状为活动后胸痛,多位于心前区或胸骨后,呈压榨样,可伴有出汗、肩背部不适,每次持续数分钟至数十分钟,休息或含服硝酸甘油可缓解。这是每个医生、甚至许多病人都知道的症状,但是很多时候,病人的表现常常极不典型。

Heart:瑞典地区23年间心肌梗死后的生存性别差异调查!

近期,一项发表在杂志Heart上的全国性研究中,研究者们调查了急性心肌梗死(AMI)后生存性别差异的年龄特异性和性别特征趋势,此项研究的受试人群包括了在医院外发生的冠心病(CHD)死亡。此项研究在瑞典进行,为观察性研究,研究对象为1987-2010年间年龄在35-84岁的658110名首次发生CHD事件的患者(35.7%的女性)。此项研究结果显示:年龄调整的28天病例死亡率由23.5%下降至8.5

重复:JAMA:高血钙,高风险

2017年7月25日在线发表于《JAMA》杂志的一项研究显示,对于易感体质人群而言,高血钙水平与冠状动脉心脏病和心肌梗死风险相关。

Baidu
map
Baidu
map
Baidu
map